Vera Therapeutics Inc share price logo

Vera Therapeutics Inc

NASDAQ: VERA

Mid Cap

$35.88

-0.71

(-1.95%)

as on

Vera Therapeutics Inc Stock Performance

as on May 8, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $34.47
    $36.90
    downward going graph

    3.93%

    Downside

    2.84%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $18.76
    $56.05
    downward going graph

    47.71%

    Downside

    56.22%

    Upside

    downward going graph

Vera Therapeutics Inc share price movements today

Previous Close
$36.59
Open
$36.47
Volume
932.9K
Day's Low - High
$34.47 - $36.90
52 Week Low - High
$18.76 - $56.05

Vera Therapeutics Inc Historical Returns

1 Month Return
-11.03 %
3 Month Return
-17.52 %
1 Year Return
+ 62.87 %
3 Year Return
+ 374.6 %
5 Year Return
0 %

Vera Therapeutics Inc Stock Fundamentals & Key Indicators

Check Vera Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.6B

EPS (TTM)

-5.2565

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-315.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-50.71%

Vera Therapeutics Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Vera Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Vera Therapeutics Inc image
Vera Therapeutics Inc
BUY$2.6BNANA0.00%

Stock Returns calculator for Vera Therapeutics Inc Stock including INR - Dollar returns

The Vera Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Vera Therapeutics Inc investment value today

Current value as on today

₹1,81,167

Returns

₹81,167

(+81.17%)

Returns from Vera Therapeutics Inc Stock

₹62,869 (+62.87%)

Dollar Impact

₹18,298 (+18.3%)

Analyst Recommendation on Vera Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Vera Therapeutics Inc. Average target price of $79

Vera Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Vera Therapeutics Inc.

What analysts predicted

54.58%UPSIDE

Target Price

$79

Current Price

$35.88

Analyzed by

16 Analysts

Target

$79.00

Vera Therapeutics Inc target price $79, a slight upside of 54.58% compared to current price of $35.88. According to 16 analysts rating.

Indian Investors' Interest in Vera Therapeutics Inc Stock

Search interest for Vera Therapeutics Inc Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:4% versus previous 30 day period

Vera Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-
-
-
-
0
0
1
Operating Income
-21
-27
-31
-37
-49
-48
-57
-80
-83
-94
EBITDA
-19
-27
-27
-30
-44
-41
-49
-74
-77
-85
Interest Expense
0
1
1
1
1
1
1
1
1
5
Depreciation
-1
-1
-1
1
0
0
0
0
0
0
Income Before Tax
-20
-25
-28
-33
-46
-43
-51
-76
-80
-91
Income Tax Expense
1
0
0
-
-
0
-
-
-
0
Net Income
-20
-25
-28
-33
-46
-43
-51
-76
-80
-91
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vera Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
1
-
-
Gross Profit
0
0
0
0
1
-2
0
Operating Income
-11
-48
-34
-90
-102
-167
-315
EBITDA
-11
-52
-34
-91
-92
-144
-291
Interest Expense
0
0
0
0
3
7
7
Depreciation
0
0
0
0
-3
0
0
Income Before Tax
-11
-53
-32
-89
-95
-152
-299
Income Tax Expense
0
0
0
0
0
0
0
Net Income
-11
-53
-32
-89
-95
-152
-299
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-5155.21%
0.00%
0.00%

Vera Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-25
-28
-33
-46
-43
-51
-76
-80
-91
Operating Cash Flow
-25
-33
-24
-36
-39
-54
-54
-61
-69
Investing Cash Flow
18
-219
-22
38
-221
15
28
69
80
Financing Cash Flow
24
276
3
0
325
1
20
0
286
Change in Cash
18
23
-44
2
65
-37
-5
8
296

Vera Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-53
-32
-89
-95
-152
-299
Operating Cash Flow
-34
-23
-67
-92
-134
-241
Investing Cash Flow
0
-4
-70
-39
-425
194
Financing Cash Flow
85
53
101
133
606
308
Change in Cash
50
25
-36
1
46
262

Global Institutional Holdings in Vera Therapeutics Inc

Funds
Holdings
Pictet Asset Manangement SA
1.47%
Tri Locum Partners LP
1.67%
Deep Track Capital, LP
3.93%
Vestal Point Capital LP
4.86%
Bellevue Group AG
2.37%
See all

Vera Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 07 January

    Wed, 10:59 PM

    -

    Vera Therapeutics shares rose after FDA accepted atacicept BLA for priority review, targeting IgAN treatment.

Insights on Vera Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, VERA stock has moved up by 384.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, VERA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, VERA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 31.34% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vardhman Textiles Ltd has given 86.5% return, outperforming this stock by 89.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.66% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vardhman Textiles Ltd has given 26.2% return, outperforming this stock by 21.6%

About Vera Therapeutics Inc

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
OrganisationVera Therapeutics Inc
Headquarters2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
IndustryBiotechnology
CEODr. Marshall W. Fordyce M.D.
E-voting on sharesClick here to vote

Key Management of Vera Therapeutics Inc

Name

Title

Mr. Sean P. Grant M.B.A.

Chief Financial Officer

Mr. David L. Johnson M.B.A.

Chief Opearating Officer

Dr. Robert M. Brenner M.D.

Chief Medical Officer

Mr. Joseph R. Young M.B.A.

Senior VP of Finance & Chief Accounting Officer

Ms. S. Sandra Park J.D.

Senior VP of Legal, Healthcare,Commercial Law, Compliance & Operations

Dr. Marshall W. Fordyce M.D.

Founder, President, CEO & Director

Mr. William D. Turner

Chief Regulatory Officer

Dr. Jane Wright-Mitchell J.D., Pharm.D.

Chief Legal Officer & Secretary

Ms. Debra Charlesworth

Vice President of Corporate Communications

Ms. Emma Haywood

Vice President of Marketing

FAQs

What is Vera Therapeutics Inc share price today?

Vera Therapeutics Inc share price today is $35.88 as on at the close of the market. Vera Therapeutics Inc share today touched a day high of $36.9 and a low of $34.47.

What is the 52 week high and 52 week low for Vera Therapeutics Inc share?

Vera Therapeutics Inc share touched a 52 week high of $56.05 on and a 52 week low of $18.76 on . Vera Therapeutics Inc stock price today i.e. is closed at $35.88,which is 35.99% down from its 52 week high and 91.26% up from its 52 week low.

What is Vera Therapeutics Inc's market capitalisation today?

Vera Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Vera Therapeutics Inc Stock (VERA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vera Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vera Therapeutics Inc Shares that will get you 0.0418 shares as per Vera Therapeutics Inc share price of $35.88 per share as on May 8, 2026 at 8:45 am IST.

What is the minimum amount required to buy Vera Therapeutics Inc Stock (VERA) from India?

Indian investors can start investing in Vera Therapeutics Inc (VERA) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Vera Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Vera Therapeutics Inc share’s latest price of $35.88 as on May 8, 2026 at 8:45 am IST, you will get 0.2787 shares of Vera Therapeutics Inc. Learn more about fractional shares .